Please assess the completion status of the following clinical trial:

Trial Title: Stress Reduction Intervention for Women With Ischemic Heart Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Presence of ischemic heart disease as defined by one or more of the following within the last 2 years:~* Positive stress test~* Admission for ACS, PCI, or CABG~* Typical or atypical ischemic symptoms within one month of enrollment~* On stable dose of anti-anginal medications for at least 2 months~* Able and willing to provide informed consent and comply with all aspects of the protocol~* Owns a smartphone with the ability to download applications for stress reduction and activity tracking~* English-speaking (apps are not available in other languages)~Exclusion Criteria:~* Planned for revascularization during the study period~* Self-reported or chart-reviewed diagnosis of psychotic disorder including schizophrenia or schizoaffective disorder, bipolar disorder~* Current participation in a cardiac rehab program or planned participation during the study period

- Gender: FEMALE
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Early Intervention (Type: EXPERIMENTAL): Stress reduction intervention 1 time a month
- Delayed Intervention (Type: EXPERIMENTAL): Wait list Control

Based on this trial design, predict the completion outcome and termination type (if applicable).